Emend (Fosaprepitant) and Insulin glargine
Determining the interaction of Emend (Fosaprepitant) and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend (Fosaprepitant)-Insulin Glargine (U-100) Cartridge Systems and Pens
- Emend (Fosaprepitant)-Insulin Glargine (U-100) Vials
- Emend (Fosaprepitant)-Insulin Glargine (U-300) Pens
- Emend (Fosaprepitant)-Insulin glargine and lixisenatide
- Emend (Fosaprepitant)-Insulin glargine and lixisenatide Subcutaneous
- Emend (Fosaprepitant)-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Emend for Injection
- Insulin glargine-Emend Intravenous
- Insulin glargine-Emflaza
- Insulin glargine-Emflaza (Deflazacort Oral Suspension)
- Insulin glargine-Emflaza (Deflazacort Tablets)
- Insulin glargine-Emicizumab